Prostate Cancer
Provenge Fails to Live up to Dendreon's Expectations
Published in Clinical Oncology Week, January 2nd, 2012
2012 JAN 2 -- Research and Markets has announced the addition of GlobalData's new report "Provenge fails to Live up to Dendreon's Expectations" to their offering. Provenge fails to Live up to Dendreon's Expectations. The report is an essential source of information and analysis on Provcenge failure in prostate cancer therapeutics market. The report provides insights on the failure of provange and its downturn in the prostate cancer market. This report is built using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalData's team of industry...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
More Articles from Clinical Oncology Week
- Glioblastomas
Addenbrooke's Hospital Reports Research in Glioblastomas - Colon Cancer
Data on Colon Cancer Discussed by Researchers at University of Rostock - Adenocarcinomas
Findings from Medical University of South Carolina Advance Knowledge in Adenocarcinomas - Squamous Cell Carcinoma
Findings in Squamous Cell Carcinoma Reported from China Medical University - Glioblastomas
Investigators at Justus-Liebig-University Zero in on Glioblastomas - Squamous Cell Carcinoma
Investigators from Department of Pathology Zero in on Squamous Cell Carcinoma - More from this issue of Clinical Oncology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
